BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 4,535.00
+35.00 (0.78%)
Last updated: Apr 17, 2025
BioNote Market Cap
BioNote has a market cap or net worth of 459.17 billion as of April 17, 2025. Its market cap has decreased by -2.19% in one year.
Market Cap
459.17B
Enterprise Value
57.68B
Revenue
102.78B
Ranking
n/a
PE Ratio
8.36
Stock Price
4,535.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 459.17B, a decrease of -57.68%. That is a compound annual growth rate of -30.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2025 | 459.17B | -4.48% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.66T |
| Celltrion | 33.89T |
| ALTEOGEN | 20.94T |
| Yuhan | 8,636.87B |
| SK Biopharmaceuticals | 8,207.23B |
| HLB Co., Ltd. | 7,214.15B |
| Peptron | 4,195.85B |
| LigaChem Biosciences | 3,856.78B |